Caroline Young - Net Worth and Insider Trading

Caroline Young Net Worth

The estimated net worth of Caroline Young is at least $27,814 dollars as of 2024-05-02. Caroline Young is the Director of Cumberland Pharmaceuticals Inc and owns about 19,587 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $27,814. Details can be seen in Caroline Young's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caroline Young has not made any transactions after 2022-12-20 and currently still holds the listed stock(s).

Transaction Summary of Caroline Young

To

Caroline Young Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Caroline Young owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of Caroline Young’s form 4 insider trades.

Insider Ownership Summary of Caroline Young

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2022-12-20 director

Caroline Young Latest Holdings Summary

Caroline Young currently owns a total of 1 stock. Caroline Young owns 19,587 shares of Cumberland Pharmaceuticals Inc (CPIX) as of December 20, 2022, with a value of $27,814.

Latest Holdings of Caroline Young

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2022-12-20 19,587 1.42 27,814

Holding Weightings of Caroline Young


Caroline Young Form 4 Trading Tracker

According to the SEC Form 4 filings, Caroline Young has made a total of 18 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 379 shares on December 20, 2022, which cost Caroline Young around $849.

Insider Trading History of Caroline Young

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Caroline Young Trading Performance

GuruFocus tracks the stock performance after each of Caroline Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caroline Young is 2.96%. GuruFocus also compares Caroline Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Caroline Young within 3 months outperforms 9 times out of 18 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Caroline Young's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Caroline Young

Average Return

Average return per transaction

Outperforming Transactions

0 out of 18 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.3
Relative Return to S&P 500(%) -2.23

Caroline Young Ownership Network

Ownership Network List of Caroline Young

No Data

Ownership Network Relation of Caroline Young


Caroline Young Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

Caroline Young is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include Vice Pres Sales & Marketing Chris T. Bitterman , Vice Pres Organizational Dev Todd M. Anthony , and director & 10 percent owner & Chairman and CEO A J Kazimi .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, Caroline Young made 2 insider transaction in Cumberland Pharmaceuticals Inc (CPIX) with a net purchase of 799. Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 5,255 shares made by Kenneth Krogulski , a net purchase of 2,915 shares made by Joseph C Galante , and a net purchase of 1,318 shares made by James Jones .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 10,287 shares were bought by its insiders, resulting in a net purchase of 10,287 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

Caroline Young Mailing Address

Above is the net worth, insider trading, and ownership report for Caroline Young. You might contact Caroline Young via mailing address: 2525 West End Avenue, Suite 950, Nashville Tn 37203.

Discussions on Caroline Young

No discussions yet.